Literature DB >> 10913402

Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States.

S E Reef1, S Plotkin, J F Cordero, M Katz, L Cooper, B Schwartz, L Zimmerman-Swain, M C Danovaro-Holliday, M Wharton.   

Abstract

The goal of eliminating indigenous rubella and congenital rubella syndrome (CRS) in the United States in the near future is now within reach, because rubella incidence has been sustained at record-low levels since the mid-1990s. Effective prevention strategies to eliminate CRS and rubella require improvement in the surveillance of CRS and congenital rubella infection (CRI). The purpose of the workshop was to review rubella and CRS epidemiology, as well as current clinical, diagnostic, and laboratory practices, to determine whether new strategies are needed to achieve and document CRS elimination. Workshop participants agreed that surveillance for CRS must be strengthened, particularly through augmented laboratory capabilities, and the case definition for CRS must be revised to reflect the current scientific information available. Further studies of methods are needed to identify high-risk populations and geographic areas for rubella and CRS and to enhance identification of infants with CRS.

Entities:  

Mesh:

Year:  2000        PMID: 10913402     DOI: 10.1086/313928

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Identifying risk factors for rubella susceptibility in a population at risk in the United States.

Authors:  M Carolina Danovaro-Holliday; Ely R Gordon; Charles Woernle; Gary H Higginbotham; Randa H Judy; Joseph P Icenogle; Susan E Reef
Journal:  Am J Public Health       Date:  2003-02       Impact factor: 9.308

2.  Novel replicon-based reporter gene assay for detection of rubella virus in clinical specimens.

Authors:  Wen-Pin Tzeng; Yumei Zhou; Joseph Icenogle; Teryl K Frey
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

3.  Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring.

Authors:  Alexander Viktorin; Rudolf Uher; Alexander Kolevzon; Abraham Reichenberg; Stephen Z Levine; Sven Sandin
Journal:  JAMA Psychiatry       Date:  2017-10-01       Impact factor: 21.596

4.  Rubella cataract and retinopathy.

Authors:  Ravi Bypareddy; Rohan Chawla; Shorya Vardhan Azad; Sudarshan Khokhar
Journal:  BMJ Case Rep       Date:  2016-06-10

5.  An outbreak investigation of congenital rubella syndrome in Solomon Islands, 2013.

Authors:  Kara N Durski; Carol Tituli; Divi Ogaoga; Jennie Musto; Cynthia Joshua; Alfred Dofai; Jennie Leydon; Eric Nilles
Journal:  Western Pac Surveill Response J       Date:  2016-02-03

6.  The burden of congenital rubella syndrome in the Philippines: results from a retrospective assessment.

Authors:  Anna Lena Lopez; Peter Francis Raguindin; Jose Jonas Del Rosario; Ramon V Najarro; Eleanor Du; Josephine Aldaba; Aida M Salonga; Andrea Kristina Monzon-Pajarillo; Alvina Pauline Santiago; Alan C Ou; Maria Joyce Ducusin
Journal:  Western Pac Surveill Response J       Date:  2017-06-13

7.  Prevalence and clinical profile of microcephaly in South America pre-Zika, 2005-14: prevalence and case-control study.

Authors:  Iêda M Orioli; Helen Dolk; Jorge S Lopez-Camelo; Daniel Mattos; Fernando A Poletta; Maria G Dutra; Flavia M Carvalho; Eduardo E Castilla
Journal:  BMJ       Date:  2017-11-21

Review 8.  Cell Cultures for Virology: Usability, Advantages, and Prospects.

Authors:  Alexander A Dolskiy; Irina V Grishchenko; Dmitry V Yudkin
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

9.  Model Comparisons of the Cost Effectiveness of Rubella Vaccination Method in Japanese Adults.

Authors:  Tomoya Itatani; Ryo Horiike; Hisao Nakai; Kazuya Taira; Chika Honda; Fumie Shirai; Kaoru Konishi
Journal:  Vaccines (Basel)       Date:  2021-03-08

10.  A visual approach to the economic evaluation of vaccines: opening the health economic black box.

Authors:  Enoch Kung; Maria Vittoria Bufali; Alec Morton
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2021-03-18       Impact factor: 2.217

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.